HIV-preventing PrEP drugs ‘safe for teens’ finds new study
PrEP, which if taken regularly can be used to protect against HIV transmission, is safe to be used by adolescents, a new study has found.
A diverse group of teen at high risk of HIV-transmission tolerated the PrEP drugs well in a new study.
Speaking to Reuters, lead author Sybil Hosek, a clinical psychologist and HIV researcher at Cook County Health and Hospitals System’s Stroger Hospital in Chicago said: “I do hope clinicians increase their comfort with being able to provide PrEP to adolescents.”
Hosek has said she hopes the data will go to the FDA and will encourage the approval of the use of the pill as a preventative measure for young people.
The FDA approved PrEP for use in adults back in 2012.
78 teens aged 15 to 17 from six US cities participated at the study.
They were all HIV-negative at the start of the study but all at high risk of HIV infection.
47 participants completed the study and only three reported adverse side effects possibly relating to the PrEP medication.
“I think the safety piece is important,” Hosek told Reuters Health.
“It was well tolerated. We didn’t see many complaints about side effects. We did not see many adverse events.”
The study went over 48 weeks, and all participants received a counselling session about HIV risk.
MyPinkNews members are invited to comment on articles to discuss the content we publish, or debate issues more generally. Please familiarise yourself with our community guidelines to ensure that our community remains a safe and inclusive space for all.